These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 19174488

  • 1. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR.
    Clin Cancer Res; 2009 Feb 15; 15(4):1232-40. PubMed ID: 19174488
    [Abstract] [Full Text] [Related]

  • 2. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 15; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 4. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
    Song Y, Shen K, Xu F.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct 15; 45(10):781-6. PubMed ID: 21176562
    [Abstract] [Full Text] [Related]

  • 5. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI, Koestner DA, Matranga CB, Rollins BJ.
    Clin Cancer Res; 1999 Oct 15; 5(10):2925-38. PubMed ID: 10537362
    [Abstract] [Full Text] [Related]

  • 6. Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
    Guo L, Chen P, Zhou Y, Sun Y.
    Exp Mol Pathol; 2010 Jun 15; 88(3):401-6. PubMed ID: 20206622
    [Abstract] [Full Text] [Related]

  • 7. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L.
    Radiother Oncol; 2006 Aug 15; 80(2):185-91. PubMed ID: 16905211
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y, Shen K, Tang PP.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 15; 42(11):761-4. PubMed ID: 18307904
    [Abstract] [Full Text] [Related]

  • 9. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 15; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF, Zagorski WA, Howington JA, Zilfou JT, Knudsen ES.
    Ann Thorac Surg; 2006 Jul 15; 82(1):249-53. PubMed ID: 16798224
    [Abstract] [Full Text] [Related]

  • 11. Rhabdoid tumor growth is inhibited by flavopiridol.
    Smith ME, Cimica V, Chinni S, Challagulla K, Mani S, Kalpana GV.
    Clin Cancer Res; 2008 Jan 15; 14(2):523-32. PubMed ID: 18223228
    [Abstract] [Full Text] [Related]

  • 12. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes.
    Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2224-31. PubMed ID: 16609038
    [Abstract] [Full Text] [Related]

  • 13. Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27KIP-1.
    Achenbach TV, Müller R, Slater EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3006-14. PubMed ID: 10955778
    [Abstract] [Full Text] [Related]

  • 14. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
    Song P, Sekhon HS, Lu A, Arredondo J, Sauer D, Gravett C, Mark GP, Grando SA, Spindel ER.
    Cancer Res; 2007 Apr 15; 67(8):3936-44. PubMed ID: 17440109
    [Abstract] [Full Text] [Related]

  • 15. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
    Wirger A, Perabo FG, Burgemeister S, Haase L, Schmidt DH, Doehn C, Mueller SC, Jocham D.
    Anticancer Res; 2005 Apr 15; 25(6B):4341-7. PubMed ID: 16309238
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
    Honoki K, Yoshitani K, Tsujiuchi T, Mori T, Tsutsumi M, Morishita T, Takakura Y, Mii Y.
    Oncol Rep; 2004 May 15; 11(5):1025-30. PubMed ID: 15069542
    [Abstract] [Full Text] [Related]

  • 17. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
    Ali MA, Rosati R, Pettit GR, Kalemkerian GP.
    Anticancer Res; 1998 May 15; 18(2A):1021-6. PubMed ID: 9615758
    [Abstract] [Full Text] [Related]

  • 18. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z, Wyche JH, Sands H, Pantazis P.
    Anticancer Res; 2001 May 15; 21(3B):1823-7. PubMed ID: 11497265
    [Abstract] [Full Text] [Related]

  • 19. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T, Omura-Minamisawa M, Kang Y, Cheng C, Inoue T.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1485-95. PubMed ID: 18640498
    [Abstract] [Full Text] [Related]

  • 20. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
    Guan J, Lo M, Dockery P, Mahon S, Karp CM, Buckley AR, Lam S, Gout PW, Wang YZ.
    Cancer Chemother Pharmacol; 2009 Aug 01; 64(3):463-72. PubMed ID: 19104813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.